Skip to main content
Staff Login
Username
*
Enter your The Contraceptive Pipeline Database username.
Password
*
Enter the password that accompanies your username.
Log in
Forgot password
Toggle navigation
Echo-V
Product Overview
Development Status:
Active Development
Target:
Male
Mode:
Non-hormonal
Delivery Type:
Vas Deferens
Duration Type:
Long-acting
Description:
Echo-V is a patent-pending, ultrasound-visible polymer solution that is injected into the vas deferens. It forms a hydrogel device that acts as a semi-permeable membrane, blocking sperm while allowing fluids through. Contraline is designing the gel so that it can be dissolved and flushed out with a reversal solution. Echo-V will be inserted through Vasintomy™, a novel non-surgical procedure.
Updated date:
May 30, 2018
Vertical Tabs
Product Details
Inactive material:
polymer solution
Potential Multi-Purpose Technology (MPT):
No
Regimen:
Single insertion
Duration:
Multiple years
Partner:
Contraline, LLC
Status
Project Phase:
Early Development
Project Stage:
Lead Optimization
Began discovery in:
Prior to 2015
Status Details:
Animal trials ongoing.
Programmatic Considerations
Considerations:
Long-acting reversible contraception for men
Additional Information
Additional Information:
Contraline website
Footnotes:
Image source: http://contraline.com/wp-content/uploads/2016/04/gel-graphic-768x399.png
Download Product Report
